Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2024) Vol. 96, pp. 102267-102267
Closed Access | Times Cited: 12
Epigenetic Mechanisms of Postoperative Cognitive Impairment Induced by Anesthesia and Neuroinflammation
Katharina Rump, Michael Adamzik
Cells (2022) Vol. 11, Iss. 19, pp. 2954-2954
Open Access | Times Cited: 36
Cleavage of HDAC6 to dampen its antiviral activity by nsp5 is a common strategy of swine enteric coronaviruses
Zhuang Li, Wenwen Xiao, Zhixiang Yang, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 6
Repurposing HDAC inhibitors to enhance ribonuclease 4 and 7 expression and reduce urinary tract infection
Laura Schwartz, Matthew S. Bochter, Aaron Simoni, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 13
Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
Min Qu, Huijun Zhang, Pengyuan Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2
Nima Taefehshokr, Alex Lac, Angela M. Vrieze, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 10
Open Access | Times Cited: 4
HDAC6 Degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to Inhibit Viral Replication
Zhuang Li, Panpan Duan, Runhui Qiu, et al.
Journal of Virology (2023) Vol. 97, Iss. 5
Open Access | Times Cited: 9
Structural-based design of HD-TAC7 PROteolysis TArgeting chimeras (PROTACs) candidate transformations to abrogate SARS-CoV-2 infection
Sana Zahid, Yasir Ali, Sajid Rashid
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 14566-14581
Closed Access | Times Cited: 6
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
Flavia Trionfetti, Tonino Alonzi, Giulio Bontempi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach
Zeinab Dehghan, Seyed Amir Mirmotalebisohi, Maryam Mozafar, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 1, pp. 215-235
Closed Access | Times Cited: 1
Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Drug repurposing (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
Michela Gottardi Zamperla, Barbara Illi, Veronica Barbi, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity
Sadaf Kalsum, Mira Akber, Marco Giulio Loreti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
Denis N. Prada Gori, Santiago Matías Ruatta, Martín Fló, et al.
Frontiers in Drug Discovery (2023) Vol. 2
Open Access | Times Cited: 4
SARS-COV-2 NSP5 Antagonizes MHC II Expresion by Subverting Histone Deacetylase 2
Nima Taefehshokr, Alex Lac, Angela M. Vrieze, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Deacetylation of Histones and Non-histone Proteins in Inflammatory Diseases and Cancer Therapeutic Potential of Histone Deacetylase Inhibitors
Ezgi Man, Serap Evran
Current Genomics (2023) Vol. 24, Iss. 3, pp. 136-145
Open Access | Times Cited: 3
The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
Edoardo Cellupica, Gianluca Caprini, Gianluca Fossati, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1049-1049
Open Access | Times Cited: 2
Altered expression of DNA methyltransferases and methylation status of the TLR4 and TNF-α promoters in COVID-19
Sohair Salem, Rehab M. Mosaad, Randa S. Lotfy, et al.
Archives of Virology (2023) Vol. 168, Iss. 3
Open Access | Times Cited: 2
The epigenomic consequences of HDAC6 inactivation reveal a crucial role for P300 suggesting integrated epitherapeutic strategies
Michela Gottardi Zamperla, Barbara Illi, Veronica Barbi, et al.
Research Square (Research Square) (2024)
Open Access
Network-based multi-omics-disease-drug associations reveal drug repurposing candidates for COVID-19 disease phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
(2024)
Open Access
The Human Genetic Differences in the Outcomes of mRNA Vaccination against COVID-19: A Prospective Cohort Study
Ha-Eun Ryu, Jihyun Yoon, Ja‐Eun Choi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 626-626
Open Access
Design, Synthesis, and Biological Evaluation of Novel Aak1/Hdacs Dual Inhibitors Against Sars-Cov-2 Entry
Xiang‐Yang Ye, Nian‐Dong Mao, Yueying Xu, et al.
(2024)
Closed Access
Role of histone deacetylase inhibitors in non-neoplastic diseases
Chunxiao Zhou, Dengke Zhao, Chunyan Wu, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33997-e33997
Open Access
Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entry
Nian‐Dong Mao, Yueying Xu, Xia Yao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107973-107973
Closed Access
HDAC6-Mediated FoxO1 Acetylation And Phosphorylation Control Periodontal Inflammatory Responses
Hannah Lohner, Xiao Han, Junling Ren, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1 - Next Page

Scroll to top